Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex
暂无分享,去创建一个
N. Lindefors | S. Barati | W. O'Connor | N Lindefors | S Barati | W. T O'Connor | W. O’Connor | Nils Lindefors | William T. O'Connor
[1] Bita Moghaddam,et al. Characterization of Excitatory Amino Acid Modulation of Dopamine Release in the Prefrontal Cortex of Conscious Rats , 1996, Journal of neurochemistry.
[2] S. Potkin,et al. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[3] B. Moghaddam,et al. NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[4] J. Soghomonian,et al. MK-801 decreases striatal and cortical GAD65 mRNA levels , 1995, Neuroreport.
[5] P. Goldman-Rakic,et al. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. , 1995, Archives of general psychiatry.
[6] J. Kleinman,et al. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. , 1995, Archives of general psychiatry.
[7] P. Goldman-Rakic,et al. Modulation of memory fields by dopamine Dl receptors in prefrontal cortex , 1995, Nature.
[8] Carol A. Tamminga,et al. Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia , 1995, Neuropsychopharmacology.
[9] T. Nishikawa,et al. Dizocilpine (MK-801) elicits a tetrodotoxinsensitive increase in extracellular release of dopamine in rat medial frontal cortex , 1995, Neurochemistry International.
[10] F. Bloom,et al. Psychopharmacology: The Fourth Generation of Progress , 1995 .
[11] U. Ungerstedt,et al. Dopamine D1 and D2 receptor antagonism differentially modulates stimulation of striatal neurotransmitter levels by N-methyl-D-aspartic acid. , 1994, European journal of pharmacology.
[12] J. Krystal,et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.
[13] B. Weiss,et al. Dopaminergic and glutamatergic blocking drugs differentially regulate glutamic acid decarboxylase mRNA in mouse brain. , 1994, Brain research. Molecular brain research.
[14] N. Tashiro,et al. Effect of phenycyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study , 1994, Brain Research.
[15] V. Klimek,et al. MK-801 elevates the etracellular concentration of dopamine in the rat prefrontal cortex and increases the density of striatal dopamine D1 receptors , 1993, Brain Research.
[16] Sohee Park,et al. Schizophrenics show spatial working memory deficits. , 1992, Archives of general psychiatry.
[17] W. Löscher,et al. The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems. , 1992, European journal of pharmacology.
[18] A. Deutch,et al. Dopaminergic mechanisms in the pathogenesis of schizophrenia 1 , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[19] O. Paulsen,et al. Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors. , 1992, The Journal of pharmacology and experimental therapeutics.
[20] D. Javitt,et al. Recent advances in the phencyclidine model of schizophrenia. , 1991, The American journal of psychiatry.
[21] W. Löscher,et al. The N-methyl-d-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats , 1991, Neuroscience Letters.
[22] J. Warter,et al. Behavioural, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat , 1991, Neuroscience Letters.
[23] R. Waziri,et al. Evidence of glutamatergic deficiency in schizophrenia , 1991, Neuroscience Letters.
[24] W. Turski,et al. Excitatory amino acid antagonists and memory: Effect of drugs acting at N-methyl-d-aspartate receptors in learning and memory tasks , 1990, Neuropharmacology.
[25] P. Slater,et al. Frontal Cortical and Left Temporal Glutamatergic Dysfunction in Schizophrenia , 1989, Journal of neurochemistry.
[26] U. Ungerstedt,et al. Fast HPLC Estimation of γ‐Aminobutyric Acid in Microdialysis Perfusates: Effect of Nipecotic and 3‐Mercaptopropionic Acids , 1988, Journal of neurochemistry.
[27] D. Weinberger,et al. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism. , 1988, Archives of general psychiatry.
[28] T. Honoré,et al. Phencyclidine analogues inhibit NMDA-stimulated [3H]GABA release from cultured cortex neurons. , 1987, European journal of pharmacology.
[29] L. DeLisi,et al. Dysfunction in a prefrontal substrate of sustained attention in schizophrenia. , 1987, Life sciences.
[30] T. Robinson,et al. Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis , 1986, Brain Research Reviews.
[31] A. Thomson,et al. An N-methylaspartate receptor-mediated synapse in rat cerebral cortex: a site of action of ketamine? , 1985, Nature.
[32] M. Taylor,et al. Cognitive impairment in schizophrenia. , 1984, The American journal of psychiatry.
[33] D. J. Smith,et al. Properties of the optical isomers and metabolites of ketamine on the high affinity transport and catabolism of monoamines , 1981, Neuropharmacology.
[34] H. H. Kornhuber,et al. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia , 1980, Neuroscience Letters.
[35] U. Ungerstedt,et al. Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. , 1971, Acta physiologica Scandinavica. Supplementum.
[36] M. Toru,et al. Excitatory amino acids: implications for psychiatric disorders research. , 1994, Life sciences.
[37] Babu Subramanyam,et al. MONITORING MOLECULES IN NEUROSCIENCE , 1991 .
[38] J. Lieberman,et al. Dopaminergic mechanisms in idiopathic and drug-induced psychoses. , 1990, Schizophrenia bulletin.
[39] R. Kahn,et al. The role of serotonin in schizophrenia. , 1988, Schizophrenia bulletin.
[40] H. Meltzer,et al. Psychopharmacology : the third generation of progress , 1987 .
[41] G. Paxinos,et al. The Rat Brain in Stereotaxic Coordinates , 1983 .